Graf Akcie ITCI (Intra-Cellular Therapies Inc). Diskuze k akciím ITCI. Aktuální informace ITCI.

Základní informace o společnosti Intra-Cellular Therapies Inc (Akcie ITCI)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 3.2B
Hodnota podniku (EV) N/A
Tržby 55.748M
EBITDA N/A
Zisk -237.37
Růst v tržbách Q/Q 951.41 %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) 0.00
Forward P/E -11.00
EV/Sales 41.71
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 57.36
P/FCF N/A
Price/Book 4.87
Účetní hodnota na akcii 8.12
Hotovost na akcii 8.14
FCF vůči ceně -7.48 %
Počet zaměstnanců 383
Tržba na zaměstnance 145.555k
Profit margin -995.07 %
Operating margin -429.85 %
Gross margin 91.69 %
EBIT margin -425.72 %
EBITDA margin -1,473.56 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -11.46 %
EPS - Očekávaný růst příští rok 15.19 %
Return on assets -34.05 %
Return on equity -37.50 %
ROIC -46.88 %
ROCE -41.25 %
Dluhy/Equity 0.09
Čistý dluh/EBITDA 11.11
Current ratio 11.93
Quick Ratio 11.77
Volatilita 3.97
Beta 1.04
RSI 63.07
Cílová cena analytiků 48
Známka akcie (dle analytiků) 1.00
Insider ownership 4.95 %
Institutional ownership 91.79 %
Počet akcií 81.342M
Procento shortovaných akcií 9.23 %
Short ratio 13.49 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2013
Země United States

Finanční výsledky akcie ITCI

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$0.061-$0.246$0.331$0.091$0.577$2.737$3.118
Cost Of Goods Sold--------
Gross Profit$0.061-$0.246$0.331$0.091$0.577$2.737$3.118
Research And Development Expenses$89.125$132.167$79.419$93.832$87.718$21.226$23.028$15.487
SG&A Expenses$64.948$30.1$23.667$24.758$18.187$10.338$5.976$4.035
Other Operating Income Or Expenses--------
Operating Expenses$154.073$162.267$103.086$118.59$105.905$31.564$29.004$19.521
Operating Income$-154.012$-162.267$-102.84$-118.259$-105.814$-30.987$-26.267$-16.403
Total Non-Operating Income/Expense$6.291$7.141$4.006$2.898$1.023$0.297$-0.583$-0.155
Pre-Tax Income$-147.721$-155.126$-98.834$-115.361$-104.792$-30.69$-26.85$-16.558
Income Taxes$0.002$0.002$-1.061$1.066$0.002$0.002$0.018$0.033
Income After Taxes$-147.722$-155.127$-97.773$-116.426$-104.793$-30.692$-26.868$-16.591
Other Income--------
Income From Continuous Operations$-147.722$-155.127$-97.773$-116.426$-104.793$-30.692$-26.868$-16.591
Income From Discontinued Operations--------
Net Income$-147.722$-155.127$-97.773$-116.426$-104.793$-30.692$-26.868$-16.591
EBITDA$-154.666$-162.841$-102.196$-117.518$-104.962$-30.664$-26.244$-16.356
EBIT$-154.012$-162.267$-102.84$-118.259$-105.814$-30.987$-26.267$-16.403
Basic Shares Outstanding555546433629176
Shares Outstanding555546433629176
Basic EPS$-2.68$-2.84$-2.12$-2.69$-2.91$-1.07$-1.56$-2.96
EPS - Earnings Per Share$-2.68$-2.84$-2.12$-2.69$-2.91$-1.07$-1.56$-2.96
# 2020 2019 2018 2017 2016 2015
Current Ratio6.35839.791933.02136.857977.154212.4075
Long-term Debt / Capital------
Debt/Equity Ratio------
Gross Margin100-100100100100
Operating Margin-254090.5--41832.65-35759.95-115815.8-5367.516
EBIT Margin-254090.5--41832.65-35759.95-115815.8-5367.516
EBITDA Margin-255170.2--41570.81-35535.82-114883-5311.617
Pre-Tax Profit Margin-243711.1--40203.17-34883.55-114696.8-5316.093
Net Profit Margin-243713.7--39771.64-35205.8-114698.5-5316.37
Asset Turnover0.0002-0.00050.00090.00020.0044
Inventory Turnover Ratio------
Receiveable Turnover---3.50552.979911.1874
Days Sales In Receivables---104.1231122.48732.6261
ROE - Return On Equity-75.7521-48.826-21.5153-31.0055-22.0041-25.4585
Return On Tangible Equity-75.7521-48.826-21.5153-31.0055-22.0041-25.4585
ROA - Return On Assets-58.8098-43.4279-20.7373-29.9371-21.6469-23.4086
ROI - Return On Investment-75.7521-48.826-21.5153-31.0055-22.0041-25.4585
Book Value Per Share3.51325.78778.32338.673511.03544.0867
Operating Cash Flow Per Share-0.1591-0.41710.36760.7252-2.03960.5127
Free Cash Flow Per Share-0.1647-0.40850.3530.7479-2.0630.5142